Business Context and Reporting Period
Docebo Inc. filed this Form 6-K in May 2022 as a foreign private issuer filing on Form 40-F. The filing covers the three months ended March 31, 2022.
Financial Information
The provided filing text is the Form 6-K cover page and does not include the underlying interim financial statements, management’s discussion and analysis, or press release. Accordingly, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes Versus the Prior Comparable Period
The provided text does not contain comparative financial results or a discussion of changes from the prior-year period.
Guidance, Outlook, Risks, and Unusual Items
The filing cover page does not provide guidance, outlook commentary, risk disclosures, contingencies, or unusual items. These matters may be addressed in the referenced exhibits.
Documents Included
- Exhibit 99.1: Unaudited condensed consolidated interim financial statements for the three months ended March 31, 2022.
- Exhibit 99.2: Management’s discussion and analysis for the three months ended March 31, 2022.
- Exhibit 99.3: Press release titled “Docebo Reports First Quarter 2022 Results,” dated May 12, 2022.
- Exhibits 99.4 and 99.5: Canadian interim filing certificates signed by the CEO and CFO.
Investor Verification Items
- Verify first-quarter revenue, subscription metrics, profitability, and year-over-year growth in Exhibits 99.1–99.3.
- Review operating cash flow, cash balances, debt, and liquidity.
- Assess management’s guidance and outlook, including any changes to full-year expectations.
- Review the MD&A for material risks, contingencies, foreign-exchange effects, and unusual items.